Whitener Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-160
| Closed | -$11K | – | 500 |
|
|
2019
Q2 | $11K | Hold |
160
| – | – | 0.01% | 338 |
|
|
2019
Q1 | $12K | Buy |
160
+80
| +100% | +$6K | 0.01% | 319 |
|
|
2018
Q4 | $6K | Hold |
80
| – | – | ﹤0.01% | 351 |
|
|
2018
Q3 | $13K | Buy |
+80
| New | +$13K | 0.01% | 313 |
|
|
2018
Q2 | – | Sell |
-80
| Closed | -$8K | – | 273 |
|
|
2018
Q1 | $8K | Hold |
80
| – | – | 0.01% | 350 |
|
|
2017
Q4 | $6K | Buy |
+80
| New | +$6K | 0.01% | 358 |
|